PRESS RELEASE published on 03/13/2025 at 14:00, 1 year 7 months ago Vox Royalty Provides Development Updates and Approval of 2025 Share Repurchase Program Vox Royalty Corp. provides updates on mining royalty partners Black Cat Syndicate Limited, Orla Mining Ltd., and Galway Metals Inc. Recent developments include new acquisitions and progress towards production in Western Australia, Nevada, and Quebec Acquisitions Vox Royalty Corp. Production Mining Royalty Partners
PRESS RELEASE published on 03/13/2025 at 13:45, 1 year 7 months ago bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne bonyf secures EU Patent, pending US patent, for PerioTabs® & PerioCream, set to launch at IDS Cologne in March 2025. Products aim to revolutionize dental care practices globally Bonyf PerioTabs EU Patent PerioCream IDS Cologne
PRESS RELEASE published on 03/13/2025 at 13:41, 1 year 7 months ago Form 8.3 - Equals Group PLC Chelverton Asset Management discloses a 1.18% stake in Equals Group PLC. No other disclosures made Stake Chelverton Asset Management Equals Group PLC Disclosures 1.18%
PRESS RELEASE published on 03/13/2025 at 13:38, 1 year 7 months ago REPLY: The Board of Directors approved the draft financial statements for the year 2024 Reply S.p.A. Board of Directors approves draft financial statements for 2024, proposing dividend distribution of €1.15 per share. Positive financial indicators with increased turnover and net profit Board Of Directors Financial Statements Dividend Distribution Reply S.p.A. Positive Indicators
PRESS RELEASE published on 03/13/2025 at 13:30, 1 year 7 months ago Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses Xenetic Biosciences presents promising findings on combining DNase I with CAR T cells to enhance cancer treatment strategies at the SITC Spring Scientific 2025 Cell Therapy Meeting Xenetic Biosciences Cancer Treatment DNase I CAR T Cells SITC Spring Meeting
PRESS RELEASE published on 03/13/2025 at 13:30, 1 year 7 months ago Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform Aspire Biopharma Holdings, Inc. provides update on patent applications for Oral Mucosal Formulations of Aspirin with rapid absorption technology. Company aims to revolutionize drug delivery and improve patient outcomes Drug Delivery Technology Patent Applications Aspire Biopharma Oral Mucosal Formulations Aspirin
PRESS RELEASE published on 03/13/2025 at 13:18, 1 year 7 months ago Informations privilégiées / Autres communiqués L'Autorité de la concurrence valide l'acquisition de Galimmo par Carmila. Carmila cèdera la galerie commerciale de Villers Semeuse en 2025 Cession Acquisition Autorité De La Concurrence CARMILA Galimmo
PRESS RELEASE published on 03/13/2025 at 13:18, 1 year 7 months ago Inside Information / Other news releases French Competition Authority approves Carmila's acquisition of Galimmo, Carmila to sell Villers Semeuse shopping gallery in 2025. No significant impact on financial targets Acquisition Competition Authority CARMILA Galimmo Villers Semeuse
PRESS RELEASE published on 03/13/2025 at 13:00, 1 year 7 months ago Prince Holding Group Earns Fifth Consecutive ‘Best in Cambodia’ Award for CSR Initiatives Prince Holding Group recognized as 'Best in Country Excellence - Best in Cambodia' at the 17th Annual Global CSR & ESG Awards for sustainable development efforts. Awards highlight ongoing CSR and ESG initiatives guided by Chairman Chen Zhi Sustainable Development Prince Holding Group Chen Zhi CSR Initiatives Global CSR Awards
PRESS RELEASE published on 03/13/2025 at 13:00, 1 year 7 months ago MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain MIRA Pharmaceuticals introduces topical Ketamir-2 for neuropathic and inflammatory pain, expanding pain management portfolio with innovative targeted approach MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain Topical Treatment Inflammatory Pain
Published on 11/06/2026 at 22:15, 2 days 11 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 21 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 21 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 09:30, 25 minutes ago Shelly Group: Invitation to Earnings Webcast/Call on 11 November 2026 on Unaudited 9M 2026 Results
Published on 11/09/2026 at 09:00, 55 minutes ago Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 09:00, 55 minutes ago Municipality Finance issues a GBP 50 million tap under its MTN programme
Published on 11/09/2026 at 09:00, 55 minutes ago Municipality Finance issues EUR 47.5 million zero coupon notes under its MTN programme
Published on 11/09/2026 at 09:00, 55 minutes ago Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 11/09/2026 at 07:00, 2 hours 55 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 55 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 55 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 55 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026